This study evaluated the efficacy of postoperative Gamma Knife surgery (GKS) to the tumor cavity following gross-total resection of a brain metastasis.
开云体育世界杯赔率
进行回顾性研究疼痛。病人就医时最多700年的主诉ts who were treated for brain metastases using GKS. Forty-seven patients with pathologically confirmed metastatic disease underwent GKS to the postoperative resection cavity following gross-total resection of the tumor. Patients who underwent subtotal resection or who had visible tumor in the resection cavity on the postresection neuroimaging study (either CT or MR imaging with and without contrast administration) were excluded. Radiographic and clinical follow-up was assessed using clinic visits and MR imaging. The radiographic end point was defined as tumor growth control (no tumor growth regarding the resection cavity, and stable or decreasing tumor size for the other metastatic targets). Clinical end points were defined as functional status (assessed prospectively using the Karnofsky Performance Scale) and survival. Primary tumor pathology was consistent with lung cancer in 19 cases (40%), melanoma in 10 cases (21%), renal cell carcinoma in 7 cases (15%), breast cancer in 7 cases (15%), and gastrointestinal malignancies in 4 cases (9%). The mean duration between resection and radiosurgery was 15 days (range 2–115 days). The mean volume of the treated cavity was 10.5 cm3(range 1.75–35.45 cm3), and the mean dose to the cavity margin was 19 Gy. In addition to the resection cavity, 34 patients (72%) underwent GKS for 116 synchronous metastases observed at the time of the initial radiosurgery.
Results
The mean radiographic follow-up duration was 14 months (median 10 months, range 4–37 months). Local tumor control at the site of the surgical cavity was achieved in 44 patients (94%), and tumor recurrence at the surgical site was statistically related to the volume of the surgical cavity (p = 0.04). During follow-up, 34 patients (72%) underwent additional radiosurgery for 140 new (metachronous) metastases. At the most recent follow-up evaluation, 11 patients (23%) were alive, whereas 36 patients had died (mean duration until death 12 months, median 10 months). Patients who showed good systemic control of their primary tumor tended to have longer survival durations than those who did not (p = 0.004). At the last clinical follow-up evaluation, the mean Karnofsky Performance Scale score for the overall group was 78 (median 80, range 40–100).
Conclusion:
Radiosurgery appears to be effective in terms of providing local tumor control at the resection cavity following resection of a brain metastasis, and in the treatment of synchronous and metachronous tumors. These data suggest that radiosurgery can be used to prevent recurrence following gross-total resection of a brain metastasis.
Address correspondence to: Jason P. Sheehan, M.D., Ph.D., Department of Neurological Surgery, University of Virginia Health Sciences Center, Box 800212, Charlottesville, Virginia 22908. email:jps2f@hscmail.mcc.virginia.edu.
Please include this information when citing this paper: published online April 10, 2009; DOI: 10.3171/2008.11.JNS08818.
常EL,,WefelJS,,MaorMH,,HassenbuschSJIII,,MahajanA,&LangFF,et al.:A pilot study of neurocognitive function in patients with one to three new brain metastases initially treated with stereotactic radiosurgery alone.开云体育app官方网站下载入口60:277–284,2007
常
EL
,
Wefel
JS
,
Maor
MH
,
Hassenbusch
SJ
III
,
Mahajan
A
,
Lang
FF
,
:
A pilot study of neurocognitive function in patients with one to three new brain metastases initially treated with stereotactic radiosurgery alone
.开云体育app官方网站下载入口
60
:
277
–
284
,
2007)| false
CoiaLR,,AaronsonN,,LinggoodR,,LoefflerJ,&PriestmanTJ:A report of the consensus workshop panel on the treatment of brain metastases.Int J Radiat Oncol Biol Phys23:223–227,1992
Coia
LR
,
Aaronson
N
,
Linggood
R
,
Loeffler
J
,
Priestman
TJ
:
A report of the consensus workshop panel on the treatment of brain metastases
.Int J Radiat Oncol Biol Phys
23
:
223
–
227
,
1992)| false
DagnewE,,KanskiJ,,McDermottMW,,SneedPK,,McPhersonC,&BrenemanJC,et al.:Management of newly diagnosed single brain metastasis using resection and permanent iodine-125 seeds without initial whole-brain radiotherapy: a two institution experience.Neurosurg Focus22:3E3,2007
Dagnew
E
,
Kanski
J
,
McDermott
MW
,
Sneed
PK
,
McPherson
C
,
Breneman
JC
,
:
Management of newly diagnosed single brain metastasis using resection and permanent iodine-125 seeds without initial whole-brain radiotherapy: a two institution experience
.Neurosurg Focus
22
:
3
E3
,
2007)| false
DavisPC,,HudginsPA,,PetermanSB,&HoffmanJCJr:Diagnosis of cerebral metastases: double-dose delayed CT vs contrast-enhanced MR imaging.AJNR Am J Neuroradiol12:293–300,1991
Davis
PC
,
Hudgins
PA
,
Peterman
SB
,
Hoffman
JC
Jr
:
Diagnosis of cerebral metastases: double-dose delayed CT vs contrast-enhanced MR imaging
.AJNR Am J Neuroradiol
12
:
293
–
300
,
1991)| false
GasparL,,ScottC,,RotmanM,,AsbellS,,PhillipsT,&沃瑟曼T,et al.:递归分区分析;is (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials.Int J Radiat Oncol Biol Phys37:745–751,1997
Gaspar
L
,
Scott
C
,
Rotman
M
,
Asbell
S
,
Phillips
T
,
沃瑟曼
T
,
:
递归分区分析;is (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials
.Int J Radiat Oncol Biol Phys
37
:
745
–
751
,
1997)| false
GutierrezAN,,WesterlyDC,,TomeWA,,JaradatHA,,MackieTR,&BentzenSM,et al.:Whole brain radiotherapy with hippocampal avoidance and simultaneously integrated brain metastases boost: a planning study.Int J Radiat Oncol Biol Phys69:589–597,2007
Gutierrez
AN
,
Westerly
DC
,
Tome
WA
,
Jaradat
HA
,
Mackie
TR
,
Bentzen
SM
,
:
Whole brain radiotherapy with hippocampal avoidance and simultaneously integrated brain metastases boost: a planning study
.Int J Radiat Oncol Biol Phys
69
:
589
–
597
,
2007)| false
JagannathanJ,,PetitJH,,BalsaraK,,HudesR,&ChinLS:Long-term survival after gamma knife radiosurgery for primary and metastatic brain tumors.Am J Clin Oncol27:441–444,2004
Jagannathan
J
,
Petit
JH
,
Balsara
K
,
Hudes
R
,
Chin
LS
:
Long-term survival after gamma knife radiosurgery for primary and metastatic brain tumors
.Am J Clin Oncol
27
:
441
–
444
,
2004)| false
KreslJ,,PueschelJ,,PorterR,,杨ydF4y2BaE,,McDermottM,&SneedP:Surgical resection and postoperative radiosurgery for single brain metastases.Neuro Oncol5:338,2003.(Abstract)
Kresl
J
,
Pueschel
J
,
Porter
R
,
杨ydF4y2Ba
E
,
McDermott
M
,
Sneed
P
:
Surgical resection and postoperative radiosurgery for single brain metastases
.Neuro Oncol
5
:
338
,
2003
.
(Abstract))| false
LunsfordLD,&FlickingerJC:Radiosurgery plus or minus whole brain radiation therapy for the treatment of brain metastases. An editorial comment.Surg Neurol66:461–462,2006
Lunsford
LD
,
Flickinger
JC
:
Radiosurgery plus or minus whole brain radiation therapy for the treatment of brain metastases. An editorial comment
.Surg Neurol
66
:
461
–
462
,
2006)| false
MathieuD,,KondziolkaD,,FlickingerJC,,FortinD,,KennyB,&MichaudK,et al.:Tumor bed radiosurgery after resection of cerebral metastases.开云体育app官方网站下载入口[epub ahead of print]2008
Mathieu
D
,
Kondziolka
D
,
Flickinger
JC
,
Fortin
D
,
Kenny
B
,
Michaud
K
,
:
Tumor bed radiosurgery after resection of cerebral metastases
.开云体育app官方网站下载入口
[epub ahead of print]
2008)| false
MehtaMP,,RodrigusP,,TerhaardCH,,饶A,,SuhJ,&RoaW,et al.:Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases.J Clin Oncol21:2529–2536,2003
Mehta
MP
,
Rodrigus
P
,
Terhaard
CH
,
饶
A
,
Suh
J
,
Roa
W
,
:
Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases
.J Clin Oncol
21
:
2529
–
2536
,
2003)| false
MehtaMP,,ShapiroWR,,GlantzMJ,,PatchellRA,,WeitznerMA,&MeyersCA,et al.:Lead-in phase to randomized trial of motexafin gadolinium and whole-brain radiation for patients with brain metastases: centralized assessment of magnetic resonance imaging, neurocognitive, and neurologic end points.J Clin Oncol20:3445–3453,2002
Mehta
MP
,
Shapiro
WR
,
Glantz
MJ
,
Patchell
RA
,
Weitzner
MA
,
Meyers
CA
,
:
Lead-in phase to randomized trial of motexafin gadolinium and whole-brain radiation for patients with brain metastases: centralized assessment of magnetic resonance imaging, neurocognitive, and neurologic end points
.J Clin Oncol
20
:
3445
–
3453
,
2002)| false
MeyersCA,,SmithJA,,BezjakA,,MehtaMP,,LiebmannJ,&IllidgeT,et al.:Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial.J Clin Oncol22:157–165,2004
Meyers
CA
,
Smith
JA
,
Bezjak
A
,
Mehta
MP
,
Liebmann
J
,
Illidge
T
,
:
Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial
.J Clin Oncol
22
:
157
–
165
,
2004)| false
MintzBJ,,TuhrimS,,AlexanderS,,杨WC,&ShanzerS:Intracranial metastases in the initial staging of bronchogenic carcinoma.Chest86:850–853,1984
Mintz
BJ
,
Tuhrim
S
,
Alexander
S
,
杨
WC
,
Shanzer
S
:
Intracranial metastases in the initial staging of bronchogenic carcinoma
.Chest
86
:
850
–
853
,
1984)| false
MuacevicA,,KrethFW,,HorstmannGA,,Schmid-ElsaesserR,,WowraB,&SteigerHJ,et al.:Surgery and radiotherapy compared with gamma knife radiosurgery in the treatment of solitary cerebral metastases of small diameter.J Neurosurg91:35–43,1999
Muacevic
A
,
Kreth
FW
,
Horstmann
GA
,
Schmid-Elsaesser
R
,
Wowra
B
,
Steiger
HJ
,
:
Surgery and radiotherapy compared with gamma knife radiosurgery in the treatment of solitary cerebral metastases of small diameter
.J Neurosurg
91
:
35
–
43
,
1999)| false
NiederC,,SchwerdtfegerK,,SteudelWI,&SchnabelK:复发和后期的模式toxicity after resection and whole-brain radiotherapy for solitary brain metastases.Strahlenther Onkol174:275–278,1998
Nieder
C
,
Schwerdtfeger
K
,
Steudel
WI
,
Schnabel
K
:
复发和后期的模式toxicity after resection and whole-brain radiotherapy for solitary brain metastases
.Strahlenther Onkol
174
:
275
–
278
,
1998)| false
PackerRJ:Radiation-induced neurocognitive decline: the risks and benefits of reducing the amount of whole-brain irradiation.Curr Neurol Neurosci Rep2:131–133,2002
Packer
RJ
:
Radiation-induced neurocognitive decline: the risks and benefits of reducing the amount of whole-brain irradiation
.Curr Neurol Neurosci Rep
2
:
131
–
133
,
2002)| false
PatchellRA,&RegineWF:The rationale for adjuvant whole brain radiation therapy with radiosurgery in the treatment of single brain metastases.Technol Cancer Res Treat2:111–115,2003
Patchell
RA
,
Regine
WF
:
The rationale for adjuvant whole brain radiation therapy with radiosurgery in the treatment of single brain metastases
.Technol Cancer Res Treat
2
:
111
–
115
,
2003)| false
PatchellRA,,TibbsPA,,RegineWF,,DempseyRJ,,MohiuddinM,&KryscioRJ,et al.:Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial.JAMA280:1485–1489,1998
Patchell
RA
,
Tibbs
PA
,
Regine
WF
,
Dempsey
RJ
,
Mohiuddin
M
,
Kryscio
RJ
,
:
Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial
.JAMA
280
:
1485
–
1489
,
1998)| false
PatchellRA,,TibbsPA,,WalshJW,,DempseyRJ,,MaruyamaY,&KryscioRJ,et al.:A randomized trial of surgery in the treatment of single metastases to the brain.N Engl J Med322:494–500,1990
Patchell
RA
,
Tibbs
PA
,
Walsh
JW
,
Dempsey
RJ
,
Maruyama
Y
,
Kryscio
RJ
,
:
A randomized trial of surgery in the treatment of single metastases to the brain
.N Engl J Med
322
:
494
–
500
,
1990)| false
RegineWF,,RogozinskaA,,KryscioRJ,,TibbsPA,,YoungAB,&PatchellRA:递归分区分析;is classifications I and II: applicability evaluated in a randomized trial for resected single brain metastases.Am J Clin Oncol27:505–509,2004
Regine
WF
,
Rogozinska
A
,
Kryscio
RJ
,
Tibbs
PA
,
Young
AB
,
Patchell
RA
:
递归分区分析;is classifications I and II: applicability evaluated in a randomized trial for resected single brain metastases
.Am J Clin Oncol
27
:
505
–
509
,
2004)| false
RogersLR,,RockJP,,SillsAK,,VogelbaumMA,,SuhJH,&EllisTL,et al.:Results of a phase II trial of the GliaSite radiation therapy system for the treatment of newly diagnosed, resected single brain metastases.J Neurosurg105:375–384,2006
Rogers
LR
,
Rock
JP
,
Sills
AK
,
Vogelbaum
MA
,
Suh
JH
,
Ellis
TL
,
:
Results of a phase II trial of the GliaSite radiation therapy system for the treatment of newly diagnosed, resected single brain metastases
.J Neurosurg
105
:
375
–
384
,
2006)| false
SchackertG,,SteinmetzA,,MeierU,&SobottkaSB:Surgical management of single and multiple brain metastases: results of a retrospective study.Onkologie24:246–255,2001
Schackert
G
,
Steinmetz
A
,
Meier
U
,
Sobottka
SB
:
Surgical management of single and multiple brain metastases: results of a retrospective study
.Onkologie
24
:
246
–
255
,
2001)| false
SheehanJ,,NiranjanA,,FlickingerJC,,KondziolkaD,&LunsfordLD:The expanding role of neurosurgeons in the management of brain metastases.Surg Neurol62:32–41,2004
Sheehan
J
,
Niranjan
A
,
Flickinger
JC
,
Kondziolka
D
,
Lunsford
LD
:
The expanding role of neurosurgeons in the management of brain metastases
.Surg Neurol
62
:
32
–
41
,
2004)| false
SykE,,TorkzadMR,,BlomqvistL,,LjungqvistO,&GlimeliusB:Radiological findings do not support lateral residual tumour as a major cause of local recurrence of rectal cancer.Br J Surg93:113–119,2006
Syk
E
,
Torkzad
MR
,
Blomqvist
L
,
Ljungqvist
O
,
Glimelius
B
:
Radiological findings do not support lateral residual tumour as a major cause of local recurrence of rectal cancer
.Br J Surg
93
:
113
–
119
,
2006)| false
VechtCJ,,Haaxma-ReicheH,,NoordijkEM,,PadbergGW,,VoormolenJH,&HoekstraFH,et al.:Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery?.Ann Neurol33:583–590,1993
Vecht
CJ
,
Haaxma-Reiche
H
,
Noordijk
EM
,
Padberg
GW
,
Voormolen
JH
,
Hoekstra
FH
,
:
Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery?
.Ann Neurol
33
:
583
–
590
,
1993)| false
